CARL ZEISS MEDITEC revenue for the last year amounted to 1.95 B CHF, the most of which — 1.50 B CHF — came from its highest performing source at the moment, Ophthalmology, the year earlier bringing 1.53 B CHF. The greatest contribution to the revenue figure was made by Asia Pacific — last year it brought CARL ZEISS MEDITEC 894.80 M CHF, and the year before that — 968.51 M CHF.